Ventures

Asante Solutions, Inc. developed an easy-to-use, disposable insulin pump that was affordable, reliable, and had strong appeal to patients in terms of user friendliness and physical appearance.

Amplyx Pharmaceuticals develops innovative therapies for debilitating and life-threatening diseases that affect people with compromised immune systems.

Developed a biologic to treat the orphan eye disorder Graves Orbitopathy, a very debilitating condition that ultimately can lead to blindness.

Enterome is pioneering the development of novel microbiome based drugs to treat cancer and GI track related disorders.

BONESUPPORT has a platform for delivering drugs to bone using CERAMENT™ - IPO in 2017 – BONEX (Nasdaq Stockholm).

Veloxis has developed Envarsus® XR (once daily tacrolimus extended-release tablets) based upon the company’s delivery technology, MeltDose®.

Aura Biosciences is a biopharmaceutical company aiming to transform the treatment of early-stage tumours to prevent metastasis and improve outcomes for patients with cancer.

scPharmaceuticals provides subcutaneous administration of therapies that have previously been limited to intravenous, or IV, delivery reducing overall healthcare costs and advances the quality and convenience of care.

VarmX is a drug development company, developing drugs to restore haemostasis in case of bleeding or emergency surgery in patients taking oral factor Xa inhibitors.

Was in phase II/III trial with a SERCa2a gene therapy to help heart failure patients hearts to beat without increasing their oxygen consumption.